What’s Old is New Again – A Review of the Current Evidence of Colchicine in Cardiovascular Medicine

Author(s): Bryan P. Yan , Guang-Ming Tan .

Journal Name: Current Cardiology Reviews

Volume 13 , Issue 2 , 2017

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Colchicine is a well-established drug approved by the Food and Drug Administration (FDA) for the prevention and treatment of gout. It possesses unique anti-inflammatory properties. Interests in the usage of colchicine in cardiovascular medicine have been rekindled recently with several large trials been carried out to investigate its efficacy in treatment of various cardiac conditions including pericarditis, postpericardiotomy syndrome, atrial fibrillation and coronary artery disease. In this review, the basic pharmacological properties of colchicine will be discussed, and the evidences of its benefits for different applications in cardiovascular medicine will be reviewed.

Keywords: Colchicine, pericarditis, postpericardiotomy syndrome, atrial fibrillation, atherosclerosis.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 2
Year: 2017
Page: [130 - 138]
Pages: 9
DOI: 10.2174/1573403X12666161014094159
Price: $58

Article Metrics

PDF: 24